Direct access to end-to-end extraction methods, empirical botanical screening, in vitro/in vivo verification protocols, and pilot-to-commercial contract manufacturing.
How Chinese CDMO infrastructures have evolved from rudimentary aqueous decoction to standardized, high-precision molecular partition, chromatographic fingerprinting, and automated synthesis.
Traditional Chinese Medicine (TCM) historically relied on physical boiling, maceration, and dynamic infusions. Today, China's leading Method Of Preparation Manufacturers apply supercritical CO2 extraction, macroporous resin column chromatography, molecular distillation, and ultrafiltration membrane separation. This transition allows high-purity isolation of active components such as diterpene lactones, polyphenols, triterpenoid saponins, and polysaccharides without thermal degradation.
Quality by Design (QbD) governs the entire preparation trajectory. Chinese manufacturing hubs integrate continuous in-line High-Performance Liquid Chromatography (HPLC), High-Performance Thin-Layer Chromatography (HPTLC), and gas chromatography-mass spectrometry (GC-MS). This guarantees batch-to-batch chemical fingerprint uniformity, eliminating natural seasonal batch variations.
China's modernized preparation facilities design solvent recipes, microbial limits, and heavy-metal limits that natively comply with the United States Pharmacopeia (USP), European Pharmacopoeia (Ph. Eur.), and ChP. This ensures that validation data and drug dossiers (DMF/ASMF) are fully accepted by regulatory agencies across North America, Europe, and Asia-Pacific.
Combining vast indigenous biodiversity, vertically integrated chemical engineering clusters, and agile scale-up infrastructure.
China hosts over 12,000 recorded medicinal plant species. Preparation facilities maintain GAP-certified (Good Agricultural Practice) plantations right at the geographic origin (Daodi herbs), minimizing transit oxidation and guaranteeing superior raw biomass potency.
Engineering clusters in Hunan, Sichuan, and Zhejiang allow continuous process adaptation. Pilot plants running 50L reactors seamlessly translate thermodynamic and volumetric data into 10-ton industrial extraction columns within weeks, significantly truncating R&D lead times.
Clients save 40% to 65% of preparatory R&D expenditure compared to Western laboratories. Over 300+ full-time research scientists run simultaneous mobile phase trials, orthogonal purification runs, and stability tests without enterprise overhead strain.
Modern Chinese facilities adopt closed-loop explosion-proof solvent recovery loops (>95% recycling efficiency), low-temperature vacuum concentrators, and solar-assisted steam generators to reduce the carbon footprint per kilogram of purified botanical active.
Documented benchmarks built over 14+ years of collaborative research with China's foremost hospitals, universities, and pharmaceutical groups.
Years Phytomedicine R&D
Scientific Personnel & Chemists
Classic TCM Formulas Modernized
Hospital Preparation Registrations
Single-Herb Process Standards
Pharma Manufacturers Served
Innovative Natural Medicines Built
Proprietary IP Confidentiality
From botanical raw material taxonomy and solvent screening to pilot scale-up and finished dossier validation.
We analyze active compound density across geographic origins, harvest windows, and plant tissues (roots, leaves, seeds). This locks in baseline botanical consistency before initiating extraction chemistry.
Screening ethanol/water ratios, pressurized liquid extraction, supercritical carbon dioxide, and enzymatic pretreatment to optimize mass transfer kinetics and maximize target molecule yields.
Application of polymeric resin adsorption, liquid-liquid partitioning, crystallographic isolation, and membrane ultrafiltration to systematically strip out unwanted polysaccharides, tannins, and lipids.
Development and validation of HPLC, HPTLC, and GC assay procedures according to ICH Q2(R1) guidelines, establishing distinct fingerprint identification, quantitative markers, and impurity profiles.
Executing LD50 tests, acute/chronic systemic toxicology, genotoxicity tests (Ames), and target cell pathway bioassays to scientifically substantiate bioactivity and biosafety parameters.
Seamless parameter transfer to pilot and commercial GMP-compliant manufacturing lines, delivering high-stability concentrated liquids, microencapsulated powders, pastes, and finished dosage forms.
How our integrated CRO & CDMO preparation infrastructure resolves compliance bottlenecks for multinational pharmaceutical, dietary supplement, and personal care conglomerates.
Pain Point: Severe batch potency variation and lack of clinical proof for structure-function claims.
Solution: We engineer standardized extracts with specified marker concentrations (e.g., total ginsenosides, curcuminoids, flavonoids) alongside randomized human micro-trial validation data ready for label claim substantiation.
Pain Point: Complex regulatory barriers for natural multi-component drugs and lack of CMC documentation.
Solution: Complete CMC dossier support, ICH-compliant impurity degradation kinetics, full preclinical LD50 and Phase I–IV clinical study execution based on our track record of 22 proprietary natural drugs developed.
Pain Point: Solvent residue toxicity, color instability, and loss of efficacy in topical emulsification systems.
Solution: Clean-label aqueous/glycolic preparation protocols, decolorized active fractions, skin-permeation testing (Franz cell models), and non-animal safety certifications compliant with EU CosIng standards.
Engineered physical states designed for immediate compatibility with commercial high-speed manufacturing lines.
Produced under tightly regulated cleanroom protocols, ready for direct blending, compounding, or API formulation:
Fully packaged, blistered, bottled, and regulatory-ready oral delivery formats:
Critical insights into intellectual property protection, regulatory documentation, analytical repeatability, and scaling timelines.
Select your target research or contract manufacturing program below to request comprehensive chemical specifications, validation dossiers, and trial batches.
